Position in LLY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$423,398
+$107,917 QoQ
Shares Held
353
+2.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.43%
of 13F equity value
Holder Rank
#3,888
of 4,605 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Clark Wealth Partners holds $2,314,197 across 10 Drug Manufacturers - General names. LLY ranks #3 (18.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
4,056 | $1,020,651 | |
| 2 | MRK |
Merck & Co., Inc.
|
5,121 | $658,048 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
353 | $423,398 | |
| 4 | JNJ |
Johnson & Johnson
|
444 | $112,762 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
717 | $41,313 | |
| 6 | GSK |
GSK plc
|
456 | $23,903 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
110 | $13,897 | |
| 8 | AMGN |
Amgen Inc
|
31 | $11,225 |
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $423,398 | 353 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $315,481 | 343 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $379,362 | 353 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $269,339 | 353 | Shares | Sole | 2026-02-04 | |
| 2025-06-30 | $24,165 | 31 | Shares | Sole | 2026-02-04 | |
| 2025-03-31 | $26,429 | 32 | Shares | Sole | 2026-02-04 | |
| 2024-12-31 | $30,880 | 40 | Shares | Sole | 2026-02-04 | |
| No filing history on record for this holder in this stock. | ||||||